Showing results (1701-1710 of 1,714) with videos related to
Sort By:
Pageof 172
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 18, 2022
Clinical and echocardiographic risk factors for device-related thrombus after left atrial appendage closure: an analysis from the multicenter EUROC-DRT registryVivian Vij, Kerstin Piayda, Dominik Nelles, et al.Circulation. Cardiovascular Interventions|May 18, 2021
Device-Related Thrombus After Left Atrial Appendage Closure: Data on Thrombus Characteristics, Treatment Strategies, and Clinical Outcomes From the EUROC-DRT-RegistryAlexander Sedaghat, Vivian Vij, Baravan Al-Kassou, et al.Journal of the American College of Cardiology|September 20, 2023
Clinical Pathway for Coronary Atherosclerosis in Patients Without Conventional Modifiable Risk Factors: JACC State-of-the-Art ReviewGemma A Figtree, Stephen T Vernon, Jason A Harmer, et al.Clinical Research in Cardiology : Official Journal of the German Cardiac Society|June 9, 2023
Symptomatic vs. non-symptomatic device-related thrombus after LAAC: a sub-analysis from the multicenter EUROC-DRT registryVivian Vij, Ignacio Cruz-González, Roberto Galea, et al.The New England Journal of Medicine|August 26, 2022
Polypill Strategy in Secondary Cardiovascular PreventionJose M Castellano, Stuart J Pocock, Deepak L Bhatt, et al.The New England Journal of Medicine|August 29, 2017
Rivaroxaban with or without Aspirin in Stable Cardiovascular DiseaseJohn W Eikelboom, Stuart J Connolly, Jackie Bosch, et al.Gastroenterology|June 2, 2019
Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or AspirinPaul Moayyedi, John W Eikelboom, Jackie Bosch, et al.Gastroenterology|May 6, 2019
Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled TrialPaul Moayyedi, John W Eikelboom, Jackie Bosch, et al.BMC Endocrine Disorders|July 2, 2025
International expert consensus on surgery for type 2 diabetes mellitusMohammad Kermansaravi, Islam Omar, Nicholas Finer, et al.Metabolism: Clinical and Experimental|June 9, 2024
DCRM 2.0: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseasesYehuda Handelsman, John E Anderson, George L Bakris, et al.Pageof 172